Demapharma SRL
1.0 FTEThe score of Demapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +30 % Total assets -9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Demapharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 17,290 € | ||||
| Equity | 385,336 € | ||||
| Cash | 8,543 € | ||||
| EBITDA | 71,719 € | ||||
| Total assets | 659,253 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 23 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 23 May 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Demapharma's financial analysis
- Solvency58.5%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Demapharma
Demapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0885.178.745
- VAT number
- BE0885178745
- Peppol
- Registered · 0208:0885178745 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Nov 2006
- Registered office
- 1341 Ottignies-Louvain-la-Neuve
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Demapharma (SRL) has been based in Ottignies-Louvain-la-Neuve since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 17,290 € and equity of 385,336 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 58.5%, above the median of its sector (40.1%).
Companies similar to Demapharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Lippinois Retail sale of pharmaceutical products Brunehaut · balance sheet €1.36m
- Demeulenaere Retail sale of pharmaceutical products Roeselare · balance sheet 761,463 €
- Apotheek VAN DER Heggen Retail sale of pharmaceutical products Gavere · balance sheet €1.91m
- M. Lambrecht Retail sale of pharmaceutical products Aalst · balance sheet 516,536 €
- Ackerman - DE Pauw Retail sale of pharmaceutical products Bruges · balance sheet 872,575 €
- Agephar Retail sale of pharmaceutical products Marche-en-Famenne · balance sheet 440,640 €
- Aganju Concept Retail sale of pharmaceutical products Ganshoren · balance sheet 545,205 €
- Pharma Steenokkerzeel Retail sale of pharmaceutical products Steenokkerzeel · balance sheet €1.12m
Frequently asked questions about Demapharma
What is the revenue of Demapharma?
Demapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Demapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0885178745 for Demapharma, if the company is VAT-registered. Its company number (CBE) is 0885.178.745.
Where is the registered office of Demapharma?
According to the CBE register, the registered office of Demapharma is in 1341 Ottignies-Louvain-la-Neuve.
What is the equity of Demapharma?
At the close of the 2025 financial year, the equity of Demapharma amounts to 385,336 €, a solvency of 58.5% of total assets.
How many people work at Demapharma?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Demapharma?
The register lists 1 active mandates at Demapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Demapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →